Efficacy of M118, a Rationally-Engineered Low-Molecular-Weight Heparin, in a Canine Model of Arterial Thrombosis Ian D Fier1, Mark A Nedelman1, J Luis Guerrero2, Ganesh Venkataraman1, and Yi Wei Qi1 Momenta Pharmaceutica

First Page		Document Content
Date: 2012-06-27 15:00:31 Heparins Anatomy Low molecular weight heparin Factor X Coagulation UFH Antithrombin Partial thromboplastin time Anticoagulant Blood Coagulation system Hematology		Efficacy of M118, a Rationally-Engineered Low-Molecular-Weight Heparin, in a Canine Model of Arterial Thrombosis Ian D Fier1, Mark A Nedelman1, J Luis Guerrero2, Ganesh Venkataraman1, and Yi Wei Qi1 Momenta Pharmaceutica Add to Reading List Source URL: www.momentapharma.com Download Document from Source Website File Size: 314,43 KB Share Document on Facebook

	A M E R I C A N S O C I E T Y O F DocID: 1qkK5 - View Document
	Monday October 10th, 2016 Amphitheatre xxx The success story of a carbohydrate” ENS Paris 29 rue d’Ulm ITMO Molecular and structural basis of life Paris 5ème DocID: 1ptev - View Document
	SPECIAL AUTHORIZATION REQUEST FORM The Newfoundland and Labrador Prescription Drug Program (NLPDP) Venous Thromboembolism (VTE) Prevention Following Surgery Pharmaceutical Services Department of Health and Community Serv DocID: 1p0MX - View Document
	April 21st, 2015 Kits for which Material Safety Data Sheets are not required The kits listed below are not labelled as hazardous. Considering the Regulation (EC) N° and the OSHA regulations 29 CFRg DocID: 1gtqX - View Document
	Guideline on non-clinical and clinical development of similar biological medicinal products containing low molecular-weight-heparins DocID: 1cDQr - View Document